States Reap Rewards From Solo Suits Against Pharma; Atypical Antipsychotics May Offer Test Cases

First the federal government came knocking at their doors and then state attorneys general followed with claims of health care fraud. Now drug makers are dealing with another nemesis: states that file individual suits instead of joining multistate settlements.